Donga Ejiao: Announcement on the Action Plan to Double Improve Quality and Return
Dong-E-E-Jiao: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Dong-E-E-Jiao: Financial Report for the first half of 2024.
Dong-E-E-Jiao: Legal opinion for the first extraordinary shareholder meeting in 2024.
Dong-E-E-Jiao: Announcement on the completion of the board of directors and supervisory board's election.
Dong-E-E-Jiao: Notice about the employee representative supervisor election
Dong-E-E-Jiao: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Dong-E-E-Jiao: Statement and commitment of independent director candidate (Sun Xiaobo).
Dong-E-E-Jiao: Notice of the First Extraordinary Shareholders' Meeting in 2024
Dong-E-E-Jiao: Statement and Commitment of Independent Director Candidate (Wen Guangwei)
Dong-E-E-Jiao: Declaration and Commitment of Independent Director Candidate (Guo De'an)
Dong-E-E-Jiao: Statement and Commitment of Independent Director Nominee (Wen Guangwei)
Dong-E-E-Jiao: Statement and Commitment of Independent Director Nominee (Sun Xiaobo)
Dong-E-E-Jiao: Statement and Commitment of Independent Director Nomination (Guo De'an)
Dong-E-E-Jiao: 2023 Annual General Meeting of Shareholders Exchange Records
Dong-E-E-Jiao: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Dong-E-E-Jiao: 2023 Annual General Meeting of Shareholders Legal Opinions
Dong-E-E-Jiao: Board Secretary Work Rules
Dong-E-E-Jiao: Notice on convening the 2023 Annual General Meeting of Shareholders
Donga Ejiao: An indicative announcement on the 2023 results announcement issued by Huarun Pharmaceutical Group Co., Ltd., an indirect holding company that is the controlling shareholder
No Data